Serum Endocan Levels Predict Drug-Eluting Stent Restenosis in Patients with Stable Angina Pectoris.

Küp, Ayhan; Toprak, Cüneyt; Bayam, Emrah; Izci, Servet; Uslu, Abdulkadir; Çelik, Mehmet; Balaban, Ismail; Cersit, Sinan; Barutçu, Süleyman; Gündogmus, Pinar Demir

Küp, Ayhan; Toprak, Cüneyt; Bayam, Emrah; Izci, Servet; Uslu, Abdulkadir; Çelik, Mehmet; Balaban, Ismail; Cersit, Sinan; Barutçu, Süleyman; Gündogmus, Pinar Demir.

Afiliação

Küp A; University of Medical Sciences Kartal Kosuyolu High Specialty Education and Research Hospital.
Toprak C; University of Medical Sciences Sancaktepe Sehit Prof. Dr. Ilhan Varank Education and Research Hospital.
Bayam E; University of Medical Sciences Ümraniye Education and Research Hospital.
Izci S; University of Medical Sciences Kartal Kosuyolu High Specialty Education and Research Hospital.
Uslu A; University of Medical Sciences Kartal Kosuyolu High Specialty Education and Research Hospital.
Çelik M; University of Medical Sciences Kartal Kosuyolu High Specialty Education and Research Hospital.
Balaban I; University of Medical Sciences Kartal Kosuyolu High Specialty Education and Research Hospital.
Cersit S; University of Medical Sciences Kartal Kosuyolu High Specialty Education and Research Hospital.
Barutçu S; University of Medical Sciences Van Education and Research Hospital.
Gündogmus PD; University of Medical Sciences Sultan Abdulhamid Han Training and Research Hospital.

Acta Cardiol Sin ; 36(2): 111-117, 2020 Mar.

Article em En | MEDLINE | ID: mdl-32201461

Palavras-chave

Biomarker; Endocan; Endothelial cell-specific molecule 1; Inflammation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Acta Cardiol Sin Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google